Screener
Replimune Group REPL Operating Income
Operating Income at other companies
Other financials
Where this comes from
Reported directly by Replimune Group in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The source filing: Replimune Group’s 10-Q, filed February 3, 2026.
- Filed
- Feb 3, 2026, 8:12 AM EST
- Fiscal quarter
- Q3 FY2026
- Calendar quarter
- Q4 2025
- Accession
- 0001628280-26-004805
| Line item | Three Months Ended December 31, 2025 | Three Months Ended December 31, 2024 | Nine Months Ended December 31, 2025 | Nine Months Ended December 31, 2024 |
|---|---|---|---|---|
| Research and development | $53,140 | $48,004 | $168,860 | $135,472 |
| Selling, general and administrative | 18,728 | 18,015 | 77,721 | 46,827 |
| Total operating expenses | 71,868 | 66,019 | 246,581 | 182,299 |
| Loss from operations | (71,868) | (66,019) | (246,581) | (182,299) |
| Other income (expense): | ||||
| Research and development incentives | 341 | 376 | 1,138 | 1,222 |
| Investment income | 2,846 | 5,137 | 11,256 | 15,243 |
| Interest expense on finance lease liability | (514) | (528) | (1,553) | (1,594) |
Item 1. Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is Replimune Group's operating income?
- Replimune Group (REPL) reported operating income of -$71.87M in Q4 2025.
- How has Replimune Group's operating income changed year-over-year?
- Replimune Group's operating income decreased by 8.9% year-over-year, from -$66.02M to -$71.87M.
- What is the long-term trend for Replimune Group's operating income?
- Over 3 years (2022 to 2025), Replimune Group's operating income has grown at a 30.3% compound annual growth rate (CAGR), from -$118.31M to -$261.63M.
- What does operating income mean?
- Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.
Ask your AI about Replimune Group's operating income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude